Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: Seven-yr follow-up

Clinical Transplantation

Volumn 23, Issue 4, 2009, Pages 565-570

  Popescu, Irinel ^a   Habib, Nagy ^b   Dima, Simona ^a   Hancu, Nicolae ^c   Gheorghe, Liana ^a   Iacob, Speranta ^a   Mihaila, Mariana ^a   Dorobantu, Bogdan ^a   Matei, Emil ^a   Botea, Florin ^d  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Domino procedure; Hepatocellular carcinoma; Homozygous familial hypercholesterolemia; Liver transplantation; Stem cell autotransplantation

Indexed keywords

ALPHA FETOPROTEIN; ATORVASTATIN; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SIMVASTATIN; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; ANGIOGRAPHY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CASE REPORT; CD34 SELECTION; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY OBSTRUCTION; DOMINO LIVER TRANSPLANTATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; HOMOZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKAPHERESIS; LIVER GRAFT; LIVER TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; SYSTOLIC HEART MURMUR; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ANTIGENS, CD34; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; PYRROLES; STEM CELL TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 68349128446     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00935.x     Document Type: Article

References (27)

1. Sotiropoulos GC, Paul A, Molmenti E et al. Liver transplantation for hepatocellular carcinoma in cirrhosis within the Eurotransplant area: An additional option with "livers that nobody wants". Transplantation 2005: 7: 897.
2. Azoulay D, Samuel D, Castaing D et al. Domino liver transplants for metabolic disorders: Experience with familial amyloidotic polyneuropathy. J Am Coll Surg 1999: 6: 584.
3. Khanna A, Hart M, Nyhan WL et al. Domino liver transplantation in maple syrup urine disease. Liver Transpl 2006: 5: 876.
4. Donckier V, El NI, Closset WL et al. Domino hepatic transplantation using the liver from a patient with primary hyperoxaluria. Transplantation 2001: 9: 1346.
5. Nishizaki T, Kishikawa K, Yoshizumi T et al. Domino liver transplantation from a living related donor. Transplantation 2000: 8: 1236.
6. Wilczek HE, Larsson M, Yamamoto S et al. Domino liver transplantation. J Hepatobiliary Pancreat Surg 2008: 2: 139.
7. Ericzon BG, Larsson M, Wilczek HE. Domino liver transplantation: Risks and benefits. Transplant Proc 2008: 4: 1130.
8. Nunes F, Valente M, Pereira R et al. Domino liver transplant: Influence on the number of donors and transplant coordination. Transplant Proc 2004: 4: 916.
9. Popescu I, Simionescu M, Tulbure D et al. Homozygous familial hypercholesterolemia: Specific indication for domino liver transplantation. Transplantation 2003: 9: 1345.
10. Furtado A, Tome L, Oliveira FJ et al. Sequential liver transplantation. Transplant Proc 1997: 2: 467.
11. Bambauer R, Olbricht CJ, Schoeppe E. Low-density lipoprotein apheresis for prevention and regression of atherosclerosis: Clinical results. Ther Apher 1997: 3: 242.
12. Bilheimer DW. Portacaval shunt and liver transplantation in treatment of familial hypercholesterolemia. Arteriosclerosis 1989: 9(1 Suppl): I158.
13. Starzl TE, Bilheimer DW, Bahnson HT et al. Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984: 8391: 1382.
14. Lopez-Santamaria M, Migliazza L, Gamez M et al. Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass. J Pediatr Surg 2000: 4: 630.
15. Shirahata Y, Ohkohchi N, Kawagishi N et al. Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia. Transpl Int 2003: 4: 276.
16. Sokal EM, Ulla L, Harvengt C et al. Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications. Transplantation 1993: 2: 432.
17. Hudgins LC, Gordon BR, Parker TS et al. LDL Apheresis: An effective and safe treatment for refractory hypercholesterolemia. Cardiovasc Drug Rev 2002: 4: 271.
18. Gordon MY, Levicar N, Pai M et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006: 7: 1822.
19. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996: 11: 693.
20. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003: 9399: 1907.
21. Schmidt HH, Tietge UJ, Buettner J et al. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation. Clin Transplant 2008: 2: 180.
22. Marchesini G, Ronchi M, Forlani G et al. Cardiovascular disease in cirrhosis - a point-prevalence study in relation to glucose tolerance. Am J Gastroenterol 1999: 3: 655.
23. Houlihan DD, Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 2008: 2: 438.
24. Gordon BR, Kelsey SF, Dau PC et al. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group. Am J Cardiol 1998: 4: 407.
25. + cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008: 103: 1952.
26. Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003: 6934: 897.
27. Terai S, Sakaida I, Yamamoto N et al. An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem 2003: 4: 551.